在过度活跃的膀中达里芬素的副作用和中止率:随机对照试验的系统审查和元分析
相关实验视频
Updated: Jan 13, 2026

03:26
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
2.3K
Vineesha Veer1, Felicity Smith1, Anna Mae Scott2,3
1Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, 4226, Australia.
Naunyn-Schmiedeberg's archives of pharmacology
|January 9, 2026
概括
用于过度活动的膀 (OAB) 的达里芬素增加了口腔干燥和便秘等副作用,特别是在较高剂量时. 然而,停药率与安慰剂相似,表明尽管有不良事件,但耐受性良好.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 基于证据的医学基于证据的医学.
背景情况:
- 过度活跃的膀 (OAB) 影响了大量患者群体.
- 达里芬素是一种用于治疗OAB的处方口服药物.
- 了解停药率和不良反应 (AE) 对治疗疗效至关重要.
研究的目的:
- 系统地审查和元分析OAB患者口服达里芬素的中止率和副作用.
- 通过使用GRADE方法来评估证据的确定性.
- 为提供有关达里芬素使用的临床决策提供数据.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 在PubMed,Embase和Cochrane CENTRAL中进行的搜索.
- 使用了偏差风险评估和GRADE; 报告遵循了PRISMA指南.
主要成果:
- 包括7个RCT,共有2381名参与者.
- 使用达里芬素时,口腔干燥 (p < 0.0001,中等确定性) 和便秘 (p < 0.0001,高确定性) 的发生率较高,显示了剂量反应.
- 在达里芬素和安慰剂组之间的总中止率没有显著差异 (RR 0.93,95% CI 0.72-1.20).
结论:
- 对OAB的达里芬素处方与口腔干燥和便秘的增加有关,与剂量-反应关系有关.
- 尽管副作用较高,但达里芬素似乎被很好地容忍,与安慰剂相比,停药率相似.
- 这些发现支持达里芬素的使用,同时强调需要管理相关副作用.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
618
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
618
Urodynamic Studies: Uroflowmetry
3.3K
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
3.3K
Drugs for Treatment of Constipation-Predominant IBS
698
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
698
Urinary Tract Infection IV: Nursing Management
426
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
426
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
363
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
363
Urinary Bladder
3.1K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
3.1K

